Profund Advisors’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.27M Sell
8,790
-1,097
-11% -$292K 0.08% 174
2025
Q4
$2.44M Buy
9,887
+1,557
+19% +$328K 0.07% 173
2025
Q3
$1.47M Buy
8,330
+164
+2% +$24.5K 0.05% 248
2025
Q2
$1.12M Buy
8,166
+2,203
+37% +$324K 0.04% 277
2025
Q1
$1.08M Sell
5,963
-358
-6% -$60.2K 0.05% 280
2024
Q4
$990K Sell
6,321
-3,664
-37% -$650K 0.04% 301
2024
Q3
$1.82M Buy
9,985
+1,292
+15% +$249K 0.07% 207
2024
Q2
$1.6M Buy
8,693
+140
+2% +$23.5K 0.06% 215
2024
Q1
$1.52M Sell
8,553
-5,229
-38% -$726K 0.06% 224
2023
Q4
$1.71M Buy
13,782
+1,542
+13% +$171K 0.07% 203
2023
Q3
$1.42M Buy
12,240
+2,375
+24% +$290K 0.08% 202
2023
Q2
$1.16M Sell
9,865
-1,716
-15% -$175K 0.06% 283
2023
Q1
$927K Buy
+11,581
New +$910K 0.06% 320

Other funds holding KRYS